Thermo Fisher Scientific Inc. expanded the company’s response to the COVID-19 pandemic by developing a total antibodies test in collaboration with WuXi Diagnostics and Mayo Clinic.
https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png00PR Newswirehttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngPR Newswire2020-05-13 07:45:422020-07-20 14:38:42Thermo Fisher Scientific Response to COVID-19 Expands to Include New Serology Test
